Configuration form 6, UROGEN-CG kit for 96 reactions with CG multiplex (Candida albicans, Gardnerella vaginalis). Reagent kit for DNA qualitative detection of Candida albicans, Chlamydia trachomatis, Gardnerella vaginalis, Mycoplasma genitalium, Mycoplasma hominis, Neisseria gonorrhoeae, Trichomonas vaginalis, Ureaplasma parvum, Ureaplasma urealyticum, CMV (Human betaherpesvirus 5), HSV1 (Human alphaherpesvirus 1) and HSV2 (Human alphaherpesvirus 2) by multiplex PCR-RT.
The reagent kit is designed for examination of patients diagnosed with melanoma, papillary thyroid cancer, ovarian, colorectal and prostate cancer in order to determine an effective strategy for targeted therapy.
The reagent kit is designed for qualitative detection of Varicella–Zoster virus genomic DNA specific region.
The reagent kit is designed for determination of BRAF and KRAS genes mutation status and is used for patients examination diagnosed with tumor diseases, mainly lung cancer, in order to determine an effective strategy for targeted therapy, predict or monitor the response to cancer therapy and the risk of recurrence or metastasis, regardless of the disease stage in all population gropus.
The reagent kit in lyophilized form is designed for qualitative detection of viral respiratory infection caused by the SARS-CoV-2 coronavirus. RNA isolation from clinical material is not required.
The reagent kit is designed for qualitative Helicobacter pylori DNA detection by real-time PCR with hybridization fluorescence detection in a DNA sample isolated from clinical material in patients with suspected helicobacteriosis and associated gastrointestinal diseases.